Small Pharma Inc.
DMTTF · OTC
2/28/2023 | 2/28/2022 | 2/28/2021 | 2/29/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | – |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | – | – | 100% | – |
| R&D Expenses | $11 | $5 | $2 | – |
| G&A Expenses | $11 | $13 | $4 | – |
| SG&A Expenses | $11 | $13 | $4 | – |
| Sales & Mktg Exp. | $0 | $0 | $0 | – |
| Other Operating Expenses | $0 | $0 | $0 | – |
| Operating Expenses | $25 | $18 | $6 | – |
| Operating Income | -$25 | -$18 | -$6 | – |
| % Margin | – | – | -7,239.6% | – |
| Other Income/Exp. Net | -$0 | -$5 | -$1 | – |
| Pre-Tax Income | -$25 | -$23 | -$7 | – |
| Tax Expense | -$2 | -$1 | $0 | – |
| Net Income | -$23 | -$22 | -$7 | – |
| % Margin | – | – | -9,061.1% | – |
| EPS | -0.071 | -0.072 | -0.022 | – |
| % Growth | 0.7% | -222.1% | – | – |
| EPS Diluted | -0.071 | -0.072 | -0.022 | – |
| Weighted Avg Shares Out | 321 | 312 | 312 | – |
| Weighted Avg Shares Out Dil | 321 | 312 | 317 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | – |
| Interest Expense | $0 | $0 | $0 | – |
| Depreciation & Amortization | $0 | $0 | $0 | – |
| EBITDA | -$25 | -$22 | -$10 | – |
| % Margin | – | – | -12,447.8% | – |